1015064-91-1

Basic information

• Product Name: [4-(2,4-dimethoxy-phenyl)-5-oxo-4,5-dihydro-[1,2]dithiolo[4,3-b]pyrrol-6-yl]-carbamic acid allyl ester
• Synonyms: [4-(2,4-dimethoxy-phenyl)-5-oxo-4,5-dihydro-[1,2]dithiolo[4,3-b]pyrrol-6-yl]-carbamic acid allyl ester
• CAS NO: 1015064-91-1
• Molecular Weight: 392.456
• Mol File: 1015064-91-1.mol
• Article Data: 4

Chemical Properties

• CAS DataBase Reference: [4-(2,4-dimethoxy-phenyl)-5-oxo-4,5-dihydro-[1,2]dithiolo[4,3-b]pyrrol-6-yl]-carbamic acid allyl ester(CAS DataBase Reference)
• NIST Chemistry Reference: [4-(2,4-dimethoxy-phenyl)-5-oxo-4,5-dihydro-[1,2]dithiolo[4,3-b]pyrrol-6-yl]-carbamic acid allyl ester(1015064-91-1)
• EPA Substance Registry System: [4-(2,4-dimethoxy-phenyl)-5-oxo-4,5-dihydro-[1,2]dithiolo[4,3-b]pyrrol-6-yl]-carbamic acid allyl ester(1015064-91-1)

Safety Data

• Hazardous Substances Data: 1015064-91-1(Hazardous Substances Data)

Upstream product

• 2937-50-0 Allyl chloroformate 
• 608132-17-8 4-tertbutyl mercapto-5-tertbutyl mercapto methenyl-1-(2,4-dimethoxy-phenyl)-3-amino-1,5-dihydropyrrolidone 
• 608132-32-7 4-tertbutyl mercapto-5-tertbutyl mercapto methenyl-1-(2,4-dimethoxy-phenyl)-3-trifluoro acetamido-1,5-dihydropyrrolidone 
• 944799-69-3 N-[4-(2,4-dimethoxyphenyl)-5-oxo-4,5-dihydro[1,2]dithiolo[4,3-b]pyrrol-6-yl]-2,2,2-trifluoroacetamide 
• 608132-08-7 4-tertbutyl mercapto-5-tertbutyl mercapto methenyl-1-(2,4-dimethoxy-phenyl)-3-hydroxy-1,5-dihydropyrrolidone 

Relevant articles and documents

Synthesis of substituted 6-amino-4-(2,4-dimethoxyphenyl)-[1,2]dithiolo[ 4,3-b]pyrrol-5-ones and their raising leukocyte count activities

The design and synthesis of a series of substituted 6-amino-4-(2,4- dimethoxyphenyl)-[1,2]dithiolo[4,3-b]pyrrol- 5-ones are described. All the synthesized compounds were evaluated for raising leukocyte count activities in normal mice. Four compounds (8a,

DITHIOLOPYRROLONE COMPOUNDS, THE PREPARATION AND THE USE THEREOF

The invention discloses a dithiolopyrrolone compound represented by formula I or its pharmaceutically acceptable salts, wherein X1, R1, R2, R3, R4 are defined as in the description. The invention also